EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

Background: Polycystic ovary syndrome [PCOS] is a common disease that affected the reproductive problem. Aim: the study tried to determine the association between PCOS with the body mass index (BMI) and the effect of metformin as treatment for PCOS. Patients and Methods: This case control prospe...

Full description

Saved in:
Bibliographic Details
Main Authors: Liqaa S. Baqer, Mutaz S. Ahmeid, Amena H. Al-Obaidi
Format: Article
Language:English
Published: Tikrit University 2023-02-01
Series:Tikrit Journal of Pure Science
Subjects:
Online Access:https://tjpsj.org/index.php/tjps/article/view/865
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849427488010141696
author Liqaa S. Baqer
Mutaz S. Ahmeid
Amena H. Al-Obaidi
author_facet Liqaa S. Baqer
Mutaz S. Ahmeid
Amena H. Al-Obaidi
author_sort Liqaa S. Baqer
collection DOAJ
description Background: Polycystic ovary syndrome [PCOS] is a common disease that affected the reproductive problem. Aim: the study tried to determine the association between PCOS with the body mass index (BMI) and the effect of metformin as treatment for PCOS. Patients and Methods: This case control prospective experimental study was carried out in Kirkuk General Hospital from January 2014 to July 2014. The recruited cases divided into three groups; Group I, 68 women with normal menstrual cycle as control group; Group II, 61 cases diagnosed as a PCOS; and Group III :- 30 cases selected from group two to receive treatment with Metformin to determine the effect of the treatment on different variables. Results: The highest percentage of PCOS (36.1%) was found in those with age group between (20-25) years. Most (65.6%) of PCOS subjects were with overweight or obese. BMI mean value was (28.92±6.68) in women with PCOS, while in control the corresponding value was (25.09±4.35). FSH, and testosterone were significantly higher in women with PCOS than in control. Metformin reduced serum FSH, LH, prolactin and testosterone, with non-significant difference. Conclusion: PCOS is independently associated with elevated BMI. Metformin treatment of PCOS induced t reduction in serum testosterone and FSH, LH and serum prolactin but not reach significant level. This warranted performance a large scale clinical trial to evaluate the therapeutic effect of metformin alone or in combination with diet control approach for treatment of PCOS. These findings have implications for the pathophysiology of obesity development and management in PCOS.
format Article
id doaj-art-3ecd3ce3b449402c99ee1306895af249
institution Kabale University
issn 1813-1662
2415-1726
language English
publishDate 2023-02-01
publisher Tikrit University
record_format Article
series Tikrit Journal of Pure Science
spelling doaj-art-3ecd3ce3b449402c99ee1306895af2492025-08-20T03:29:02ZengTikrit UniversityTikrit Journal of Pure Science1813-16622415-17262023-02-0122910.25130/tjps.v22i9.865EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROMELiqaa S. BaqerMutaz S. AhmeidAmena H. Al-Obaidi Background: Polycystic ovary syndrome [PCOS] is a common disease that affected the reproductive problem. Aim: the study tried to determine the association between PCOS with the body mass index (BMI) and the effect of metformin as treatment for PCOS. Patients and Methods: This case control prospective experimental study was carried out in Kirkuk General Hospital from January 2014 to July 2014. The recruited cases divided into three groups; Group I, 68 women with normal menstrual cycle as control group; Group II, 61 cases diagnosed as a PCOS; and Group III :- 30 cases selected from group two to receive treatment with Metformin to determine the effect of the treatment on different variables. Results: The highest percentage of PCOS (36.1%) was found in those with age group between (20-25) years. Most (65.6%) of PCOS subjects were with overweight or obese. BMI mean value was (28.92±6.68) in women with PCOS, while in control the corresponding value was (25.09±4.35). FSH, and testosterone were significantly higher in women with PCOS than in control. Metformin reduced serum FSH, LH, prolactin and testosterone, with non-significant difference. Conclusion: PCOS is independently associated with elevated BMI. Metformin treatment of PCOS induced t reduction in serum testosterone and FSH, LH and serum prolactin but not reach significant level. This warranted performance a large scale clinical trial to evaluate the therapeutic effect of metformin alone or in combination with diet control approach for treatment of PCOS. These findings have implications for the pathophysiology of obesity development and management in PCOS. https://tjpsj.org/index.php/tjps/article/view/865PCOSMetforminFSHLHProlactinTestosterone
spellingShingle Liqaa S. Baqer
Mutaz S. Ahmeid
Amena H. Al-Obaidi
EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Tikrit Journal of Pure Science
PCOS
Metformin
FSH
LH
Prolactin
Testosterone
title EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
title_full EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
title_fullStr EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
title_full_unstemmed EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
title_short EVALUATION THE EFFECT OF METFORMIN ON HORMONES SERUM LEVELS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
title_sort evaluation the effect of metformin on hormones serum levels in women with polycystic ovary syndrome
topic PCOS
Metformin
FSH
LH
Prolactin
Testosterone
url https://tjpsj.org/index.php/tjps/article/view/865
work_keys_str_mv AT liqaasbaqer evaluationtheeffectofmetforminonhormonesserumlevelsinwomenwithpolycysticovarysyndrome
AT mutazsahmeid evaluationtheeffectofmetforminonhormonesserumlevelsinwomenwithpolycysticovarysyndrome
AT amenahalobaidi evaluationtheeffectofmetforminonhormonesserumlevelsinwomenwithpolycysticovarysyndrome